From: Identification and characterization of genes that control fat deposition in chickens
Alignments | Gene Symbol | Transcript ID | Gene ontology |
---|---|---|---|
chrZ:53399697-53408327 | LPL, ENSGALG00000015425 | NM_205282 | GO:0004465 lipoprotein lipase activity; |
GO:0004806 triacylglycerol lipase activity; | |||
GO:0006629 lipid metabolism; | |||
chr4:53309684-53311980 | SULT1B1, SULT1B1 | NM_204545 | GO:0006629 lipid metabolism; |
GO:0008202 steroid metabolism; | |||
chr28:1247898-1259038 | ACSBG2(RCJMB04_9i11) | NM_001012846 | 006629 lipid metabolism; |
GO:0006631 fatty acid metabolism; | |||
chr15:4477440-4512637 | AACS, ENSGALG00000002899 | NM_001006184 | GO:0006629 lipid metabolism; |
GO:0006631 fatty acid metabolism; | |||
GO:0005829 cytosol | |||
chr1:71256654-71270462 | PNPLA3 | XM_416457 | GO:0006629 lipid metabolism; |
GO:0006629 lipid metabolism; | |||
GO:0016042 lipid catabolism | |||
chr7:2296059-2312305 | FRZB, ENSGALG00000002763 | NM_204772 | GO:0017147 Wnt-protein binding; |
GO:0007275 development; | |||
GO:0016055 Wnt receptor signaling pathway | |||
chr15:8372896-8375331 | DDT(RCJMB04_2c16) | NM_001030667 | GO:0006583 melanin biosynthesis from tyrosine; |
chr1:132739051132944192 | DHRSX | XM_001232713 | GO:0055114 oxidation reduction |
chr7:6879282-6888069 | LSS | NM_001006514 | GO:0006695 cholesterol biosynthesis |
chr7:22713218-22757360 | DPP4 | NM_001031255 | GO:0005515 protein binding; |
GO:0008239 dipeptidyl-peptidase activity; | |||
GO:0042803 protein homodimerization activity; | |||
chr13:13578206-13590970 | MGAT4B | XM_414605 | GO:0005975 carbohydrate metabolism; |
chrZ:23472632-23474241 | HMGCR, ENSGALG00000014948 | NM_204485 | GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity; |
GO:0016491 oxidoreductase activity; | |||
GO:0050661 NADP binding; | |||
chr5:24711230-24725772 | ENSGALG00000008078, FUT8 | NM_001004766 | GO:0008424 glycoprotein 6-alpha-L-fucosyltransferase activity; |
GO:0046921 alpha(1,6)-fucosyltransferase activity; | |||
GO:0007179 transforming growth factor beta receptor signaling pathway | |||
chr6:28077530-28103087 | GPAM | XM_421757 | GO:0006631 fatty acid metabolism; |
GO:0019432 triacylglycerol biosynthesis; | |||
GO:0040018 positive regulation of body size; | |||
chr20:3629311-3638107 | SGK2 | XM_417346;CR387909 | GO:0004713 protein-tyrosine kinase activity; |
GO:0005524 ATP binding; | |||
chr3:34793675-34819927 | PRKD3 | XM_419526 | GO:0004713 protein-tyrosine kinase activity; |
GO:0005524 ATP binding; | |||
chr20:2633184-2647420 | ACSS2 | XM_417342 | GO:0006085 acetyl-CoA biosynthesis; |
Chr1: 64269656-64276867 | LOC418170 | XM_416401 | GO:0055114 oxidation reduction |
chr6:17648418-17654233 | CYP2C45 | SNM_001001752 | GO:0055114 oxidation reduction |
chr4:11367346-11377074 | NSDHL | XM_420279 | GO:0005975 carbohydrate metabolism; |
GO:0008203 cholesterol metabolism; | |||
chrUn_random:7545445-7546725 | FDPS | XM_422855 | GO:0006695 cholesterol biosynthesis |
chr2:144322566-144334593 | SQLE | NM_001030953 | GO:0055114 oxidation reduction; |
chr8:26011324-26019531 | DHCR24 | NM_001031288 | GO:0016125 sterol metabolism; |
chr1:64293981-64312331 | AKR1B1 | XR_026805 | GO:0055114 oxidation reduction |
chr1:118069255-119072613 | DMD | NM_205299 | GO:0007519 striated muscle development; cytoplasm; |
GO:0016010 dystrophin-associated glycoprotein complex; | |||
GO:0045121 lipid raft; | |||
chr18:4906222-4942593 | FASN, ENSGALG00000002747 | NM_205155;J02839 | GO:0000036 acyl carrier activity; |
GO:0004312 fatty-acid synthase activity; | |||
GO:0006633 fatty acid biosynthesis; | |||
chr4:59493262-59560594 | ELOVL6 | Â | GO:0006633 fatty acid biosynthesis |
chr6:11960338-11966483 | HKDC1 | XM_421579 | GO:0005524 ATP binding; |
GO:0005975 carbohydrate metabolism; | |||
GO:0006096 glycolysis; | |||
chr2:64406040-64411831 | GCNT2 | XM_426036;XM_418950 | GO:0008375 acetylglucosaminyltransferase activity; |
chr1:98522850-98669948 | GBE1 | XM_425536 | GO:0005975 carbohydrate metabolism |